4//SEC Filing
Driscoll Martin J 4
Accession 0001209191-19-031916
CIK 0001566373other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 9:10 AM ET
Size
4.6 KB
Accession
0001209191-19-031916
Insider Transaction Report
Form 4
Driscoll Martin J
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2019-05-21$6.63/sh+5,000$33,150→ 75,400 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001339402
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 9:10 AM ET
- Size
- 4.6 KB